165 related articles for article (PubMed ID: 8970522)
1. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
2. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
Neumann DR; Esselstyn CB; Maclntyre WJ; Go RT; Obuchowski NA; Chen EQ; Licata AA
J Nucl Med; 1996 Nov; 37(11):1809-15. PubMed ID: 8917180
[TBL] [Abstract][Full Text] [Related]
3. Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography.
Arslan N; Rydzewski B
Clin Nucl Med; 2002 Mar; 27(3):221-2. PubMed ID: 11852320
[No Abstract] [Full Text] [Related]
4. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
5. Preoperative imaging of parathyroid carcinoma by positron emission tomography.
Neumann DR; Esselstyn CB; Siciliano D; MacIntyre WJ; Kohse LM; Licata AA
Ann Otol Rhinol Laryngol; 1994 Sep; 103(9):741-5. PubMed ID: 8085739
[No Abstract] [Full Text] [Related]
6. Regional body FDG-PET in postoperative recurrent hyperparathyroidism.
Neumann DR; Esselstyn CB; MacIntyre WJ; Chen EQ; Go RT; Licata AA
J Comput Assist Tomogr; 1997; 21(1):25-8. PubMed ID: 9022764
[TBL] [Abstract][Full Text] [Related]
7. Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging.
Al-Sobhi S; Ashari LH; Ingemansson S
Clin Nucl Med; 1999 Jan; 24(1):21-3. PubMed ID: 9890488
[TBL] [Abstract][Full Text] [Related]
8. Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive.
Alabed YZ; Rakheja R; Novales-Diaz JA; Lisbona R
Clin Nucl Med; 2014 Jul; 39(7):e362-4. PubMed ID: 24458176
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.
Melon P; Luxen A; Hamoir E; Meurisse M
Eur J Nucl Med; 1995 Jun; 22(6):556-8. PubMed ID: 7556303
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-sestamibi SPECT localization of mediastinal parathyroid adenoma.
Teigen EL; Kilgore EJ; Cowan RJ; Albertson DA
J Nucl Med; 1996 Sep; 37(9):1535-7. PubMed ID: 8790213
[TBL] [Abstract][Full Text] [Related]
11. Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Kim SS; Jeon YK; Lee SH; Kim BH; Kim SJ; Kim YK; Kim IJ
Korean J Intern Med; 2014 May; 29(3):383-7. PubMed ID: 24851075
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.
Neumann DR; Esselstyn CB; MacIntyre WJ; Chen EQ; Go RT; Kohse LM; Licata AA
Radiology; 1994 Aug; 192(2):509-12. PubMed ID: 8029424
[TBL] [Abstract][Full Text] [Related]
13. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
[No Abstract] [Full Text] [Related]
15. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
16. Localization of an ectopic parathyroid adenoma by double-phase technetium-99m-sestamibi scintigraphy.
Caravalho J; Balingit AG; Rivera-RodrÃguez JE; Shriver CD; Koops MK
J Nucl Med; 1995 Oct; 36(10):1840-2. PubMed ID: 7562052
[TBL] [Abstract][Full Text] [Related]
17. Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
Singh H; Wale DJ; Wong KK; Gross MD; Viglianti BL
Clin Nucl Med; 2019 Feb; 44(2):148-149. PubMed ID: 30418208
[TBL] [Abstract][Full Text] [Related]
18. Localization and reoperation results for persistent and recurrent parathyroid carcinoma.
Kebebew E; Arici C; Duh QY; Clark OH
Arch Surg; 2001 Aug; 136(8):878-85. PubMed ID: 11485522
[TBL] [Abstract][Full Text] [Related]
19. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
20. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
